BioLife Solutions, Inc. BLFS
NASDAQ · United States · Health Technology
$36.78-2.07 (-5.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
BioLife Solutions (BLFS) is a leader in advanced preservation solutions for cellular matter, with strong technical momentum and a recent 3-year high. Shares are up nearly 60% over the past year. BLFS maintains a 100% “Buy” technical rating and a Trend Seeker “Buy” signal. Analyst sentiment is mixed, with most...
Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index’s 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund’s underweight position […]
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.